| 2026 |
| 07/10 | 4,670 | 4,895 | 4,565 | 4,805 | +4% | 112,400 | 397億5357万 | +15.64% |
| 07/09 | 4,435 | 4,665 | 4,360 | 4,620 | +1.32% | 109,100 | 382億2299万 | +11.73% |
| 07/08 | 4,690 | 4,800 | 4,510 | 4,560 | -1.72% | 109,000 | 377億2659万 | +10.76% |
| 07/07 | 4,800 | 4,875 | 4,615 | 4,640 | -4.13% | 136,600 | 383億8846万 | +12.92% |
| 07/06 | 4,835 | 4,965 | 4,780 | 4,840 | +3.97% | 216,800 | 400億4313万 | +18.11% |
| 07/03 | 4,450 | 4,655 | 4,410 | 4,655 | +6.16% | 155,900 | 385億1256万 | +13.93% |
| 07/02 | 4,205 | 4,495 | 4,205 | 4,385 | +2.57% | 127,200 | 362億7875万 | +7% |
| 07/01 | 4,250 | 4,305 | 4,090 | 4,275 | -1.16% | 85,100 | 353億6868万 | +3.69% |
| 06/30 | 16:00 投資単位の引下げに関する考え方及び方針等について |
| 06/30 | 16:00 事業計画及び成長可能性に関する事項 |
| 06/30 | 4,590 | 4,590 | 4,220 | 4,325 | -0.57% | 165,000 | 357億8235万 | +3.97% |
| 06/29 | 16:00 国際学会「BCVS 2026」での発表内容が日本からの最高評価アワードを受賞、および「第8回 ACS」にて招待講演（最終演者）に選出のお知らせ |
| 06/29 | 4,085 | 4,375 | 4,085 | 4,350 | +12.84% | 186,600 | 359億8918万 | +3.87% |
| 06/26 | 3,840 | 3,905 | 3,765 | 3,855 | -1.15% | 49,900 | 318億9386万 | -8.65% |
| 06/25 | 3,730 | 3,915 | 3,710 | 3,900 | +4.98% | 94,600 | 322億6616万 | -8.67% |
| 06/24 | 3,755 | 3,820 | 3,700 | 3,715 | -1.72% | 76,300 | 307億3559万 | -14.02% |
| 06/23 | 3,950 | 3,950 | 3,765 | 3,780 | -5.26% | 107,000 | 312億7336万 | -13.7% |
| 06/22 | 3,860 | 4,075 | 3,860 | 3,990 | +3.37% | 91,100 | 330億1077万 | -10.24% |
| 06/19 | 4,060 | 4,060 | 3,845 | 3,860 | -4.81% | 95,100 | 319億3523万 | -14.37% |
| 06/18 | 3,900 | 4,095 | 3,880 | 4,055 | +2.4% | 95,900 | 335億4853万 | -11.94% |
| 06/17 | 3,760 | 4,065 | 3,735 | 3,960 | +4.76% | 112,600 | 327億6256万 | -15.69% |
| 06/16 | 3,850 | 3,925 | 3,725 | 3,780 | -1.31% | 90,100 | 312億7336万 | -21.35% |
| 06/15 | 4,000 | 4,080 | 3,815 | 3,830 | -0.13% | 110,700 | 316億8703万 | -21.96% |
| 06/12 | 3,695 | 3,855 | 3,650 | 3,835 | +3.93% | 172,600 | 317億2839万 | -23.5% |
| 06/11 | 3,875 | 3,875 | 3,610 | 3,690 | -8.09% | 276,200 | 305億2875万 | -27.85% |
| 06/10 | 15:00 2026年3月期決算説明資料 |
| 06/10 | 4,070 | 4,080 | 3,910 | 4,015 | -1.11% | 115,200 | 332億1760万 | -23.07% |
| 06/09 | 4,095 | 4,230 | 4,005 | 4,060 | -0.85% | 123,900 | 335億8990万 | -23.73% |
| 06/08 | 4,165 | 4,230 | 4,040 | 4,095 | -4.66% | 161,800 | 338億7947万 | -24.54% |
| 06/05 | 4,120 | 4,470 | 4,115 | 4,295 | +2.75% | 150,400 | 355億3414万 | -22.4% |
| 06/04 | 4,325 | 4,390 | 4,180 | 4,180 | -4.24% | 94,300 | 345億8271万 | -25.81% |
| 06/03 | 4,280 | 4,420 | 4,060 | 4,365 | +0.34% | 185,600 | 361億1328万 | -24.03% |
| 06/02 | 4,435 | 4,435 | 4,230 | 4,350 | -4.61% | 246,400 | 359億8918万 | -25.68% |
| 06/01 | 4,955 | 4,960 | 4,550 | 4,560 | -7.97% | 218,000 | 377億2659万 | -23.52% |
| 05/29 | 5,000 | 5,080 | 4,920 | 4,955 | -0.9% | 68,500 | 409億9457万 | -18.25% |
| 05/28 | 5,170 | 5,260 | 4,890 | 5,000 | -4.03% | 135,800 | 413億6688万 | -18.61% |
| 05/27 | 5,000 | 5,330 | 4,965 | 5,210 | +3.99% | 115,000 | 431億428万 | -16.31% |
| 05/26 | 19:30 役員の異動に関するお知らせ |
| 05/26 | 19:30 本店移転及び定款の一部変更に関するお知らせ |
| 05/26 | 19:30 会計監査人の異動に関するお知らせ |
| 05/26 | 5,150 | 5,200 | 4,965 | 5,010 | -2.72% | 99,600 | 414億4961万 | -20.5% |
| 05/25 | 5,070 | 5,150 | 4,820 | 5,150 | +0.59% | 228,600 | 426億788万 | -19.34% |
| 05/22 | 5,230 | 5,240 | 5,070 | 5,120 | -0.97% | 111,900 | 423億5968万 | -20.77% |
| 05/21 | 5,280 | 5,290 | 5,050 | 5,170 | -0.19% | 135,700 | 427億7335万 | -20.85% |
| 05/20 | 5,390 | 5,390 | 5,040 | 5,180 | -4.07% | 185,200 | 428億5608万 | -21.59% |
| 05/19 | 5,670 | 5,730 | 5,250 | 5,400 | -3.23% | 183,000 | 446億7623万 | -19.23% |
| 05/18 | 14:10 米国心臓協会（AHA）主催の国際学会「BCVS 2026」に当社研究成果に関する演題が採択決定 |
| 05/18 | 6,200 | 6,270 | 5,420 | 5,580 | -11.15% | 297,800 | 461億6543万 | -17.42% |
| 05/15 | 15:30 2026年3月期決算短信〔日本基準〕(連結) |
| 05/15 | 6,350 | 6,420 | 6,170 | 6,280 | -1.1% | 83,500 | 519億5680万 | -7.86% |
| 05/14 | 6,690 | 6,700 | 6,300 | 6,350 | -5.08% | 98,700 | 525億3593万 | -7.2% |
| 05/13 | 6,370 | 6,730 | 6,370 | 6,690 | +5.69% | 97,300 | 553億4888万 | -2.56% |
| 05/12 | 21:30 Nakanoshima Qross Innovation Challenge 採択のお知らせ |
| 05/12 | 6,450 | 6,450 | 6,300 | 6,330 | -2.01% | 55,200 | 523億7047万 | -7.99% |
| 05/11 | 6,450 | 6,630 | 6,410 | 6,460 | +1.73% | 69,000 | 534億4600万 | -6.66% |
| 05/08 | 6,310 | 6,440 | 6,280 | 6,350 | +0.63% | 69,200 | 525億3593万 | -8.54% |
| 05/07 | 6,580 | 6,630 | 6,270 | 6,310 | -4.83% | 158,100 | 522億500万 | -9.47% |
| 05/01 | 6,600 | 6,710 | 6,580 | 6,630 | -0.45% | 64,500 | 548億5248万 | -5.31% |
| 04/30 | 6,730 | 6,730 | 6,610 | 6,660 | -1.77% | 58,900 | 551億68万 | -5.1% |
| 04/28 | 6,780 | 6,830 | 6,710 | 6,780 | -0.15% | 59,100 | 560億9348万 | -3.69% |
| 04/27 | 6,960 | 6,960 | 6,760 | 6,790 | -2.44% | 115,600 | 561億7622万 | -3.85% |
| 04/24 | 7,010 | 7,030 | 6,940 | 6,960 | -1.28% | 50,000 | 575億8269万 | -1.53% |
| 04/23 | 7,060 | 7,090 | 6,980 | 7,050 | -0.42% | 36,900 | 583億2730万 | -0.35% |
| 04/22 | 7,000 | 7,080 | 6,970 | 7,080 | +0.57% | 53,500 | 585億7550万 | -0.01% |
| 04/21 | 7,010 | 7,110 | 6,920 | 7,040 | +0.57% | 64,500 | 582億4456万 | -0.34% |
| 04/20 | 7,040 | 7,110 | 6,970 | 7,000 | -0.71% | 50,600 | 579億1363万 | -0.71% |
| 04/17 | 7,130 | 7,150 | 7,030 | 7,050 | -0.98% | 52,400 | 583億2730万 | +0.17% |
| 04/16 | 7,120 | 7,200 | 7,080 | 7,120 | +0.28% | 64,800 | 589億643万 | +1.34% |
| 04/15 | 7,090 | 7,200 | 7,060 | 7,100 | +0.57% | 67,700 | 587億4096万 | +1.2% |
| 04/14 | 6,950 | 7,070 | 6,930 | 7,060 | +2.47% | 88,800 | 584億1003万 | +0.67% |
| 04/13 | 6,970 | 6,970 | 6,850 | 6,890 | -1.85% | 96,400 | 570億356万 | -1.77% |
| 04/10 | 7,130 | 7,210 | 7,000 | 7,020 | -2.09% | 73,900 | 580億7909万 | -0.1% |
| 04/09 | 7,180 | 7,230 | 7,080 | 7,170 | 0% | 50,200 | 593億2010万 | +1.88% |
| 04/08 | 7,110 | 7,310 | 7,110 | 7,170 | +1.7% | 128,300 | 593億2010万 | +2.06% |
| 04/07 | 6,930 | 7,100 | 6,830 | 7,050 | +1.29% | 116,600 | 583億2730万 | +0.6% |
| 04/06 | 6,980 | 7,050 | 6,960 | 6,960 | +0.43% | 50,600 | 575億8269万 | -0.85% |
| 04/03 | 7,060 | 7,130 | 6,920 | 6,930 | -1.56% | 102,800 | 573億3449万 | -1.9% |
| 04/02 | 7,360 | 7,450 | 6,980 | 7,040 | -4.35% | 154,000 | 582億4456万 | -0.72% |
| 04/01 | 7,190 | 7,420 | 7,150 | 7,360 | +4.99% | 144,600 | 608億9204万 | +3.63% |
| 03/31 | 7,110 | 7,250 | 6,990 | 7,010 | -0.28% | 110,300 | 579億9636万 | -1.21% |
| 03/30 | 6,990 | 7,090 | 6,920 | 7,030 | -0.99% | 137,600 | 581億6183万 | -1.66% |
| 03/27 | 6,990 | 7,110 | 6,950 | 7,100 | +0.85% | 108,700 | 587億4096万 | -2.82% |
| 03/26 | 7,150 | 7,160 | 6,990 | 7,040 | -2.36% | 125,800 | 582億4456万 | -6.08% |
| 03/25 | 7,320 | 7,370 | 7,180 | 7,210 | -1.5% | 116,500 | 596億5104万 | -5.95% |
| 03/24 | 7,160 | 7,420 | 7,000 | 7,320 | +5.63% | 185,000 | 605億6111万 | -6.33% |
| 03/23 | 7,010 | 7,210 | 6,930 | 6,930 | -2.94% | 156,700 | 572億9776万 | -12.28% |
| 03/19 | 7,080 | 7,270 | 7,060 | 7,140 | -0.83% | 104,700 | 590億3406万 | -10.32% |
| 03/18 | 6,670 | 7,230 | 6,670 | 7,200 | +8.11% | 282,400 | 595億3014万 | -10.22% |
| 03/17 | 6,760 | 6,870 | 6,630 | 6,660 | -0.45% | 103,800 | 550億6538万 | -17.45% |
| 03/16 | 6,670 | 6,780 | 6,610 | 6,690 | 0% | 97,600 | 553億1342万 | -17.71% |
| 03/13 | 6,610 | 6,780 | 6,550 | 6,690 | -1.18% | 179,000 | 553億1342万 | -18.32% |
| 03/12 | 6,810 | 6,910 | 6,700 | 6,770 | -1.17% | 171,700 | 559億7487万 | -17.95% |
| 03/11 | 7,060 | 7,210 | 6,850 | 6,850 | -2.7% | 216,600 | 566億3632万 | -17.59% |
| 03/10 | 7,200 | 7,290 | 6,940 | 7,040 | -0.71% | 284,200 | 582億725万 | -15.81% |
| 03/09 | 7,010 | 7,250 | 6,880 | 7,090 | -1.53% | 398,800 | 586億2065万 | -15.57% |
| 03/06 | 11:00 ヒト(同種)iPS細胞由来心筋細胞シートの条件及び期限付き製造販売承認の取得について |
| 03/06 | 7,280 | 7,980 | 6,880 | 7,200 | -1.37% | 1,326,100 | 595億3014万 | -14.63% |
| 03/05 | 7,190 | 7,410 | 7,040 | 7,300 | +6.73% | 300,000 | 603億5695万 | -13.73% |
| 03/04 | 6,480 | 7,040 | 6,480 | 6,840 | +1.48% | 503,700 | 565億5363万 | -19.4% |
| 03/03 | 7,450 | 7,460 | 6,740 | 6,740 | -8.3% | 487,400 | 557億2683万 | -21.01% |
| 03/02 | 7,630 | 7,790 | 7,330 | 7,350 | -9.03% | 635,200 | 607億7035万 | -14.34% |
| 02/27 | 7,750 | 8,080 | 7,660 | 8,080 | +6.32% | 446,500 | 668億605万 | -5.93% |
| 02/26 | 7,400 | 7,950 | 7,340 | 7,600 | +4.11% | 673,700 | 628億3737万 | -11.19% |
| 02/25 | 7,380 | 7,700 | 7,210 | 7,300 | +0.97% | 737,300 | 603億5695万 | -14.88% |
| 02/24 | 7,870 | 7,900 | 7,150 | 7,230 | -13.1% | 1,202,700 | 597億7818万 | -16.14% |
| 02/20 | 11,240 | 11,830 | 8,210 | 8,320 | -24.02% | 3,380,100 | 687億6784万 | -3.85% |
| 02/19 | 20:00 ヒト(同種)iPS細胞由来心筋細胞シートの製造販売承認審査の状況について |
| 02/19 | 12,080 | 12,400 | 10,800 | 10,950 | -7.75% | 730,700 | 905億575万 | +26.36% |
| 02/18 | 11,100 | 12,300 | 10,800 | 11,870 | +5.32% | 681,100 | 981億989万 | +38.8% |
| 02/17 | 11,460 | 11,830 | 10,420 | 11,270 | +2.92% | 710,900 | 931億5067万 | +34.44% |
| 02/16 | 10,650 | 10,950 | 10,290 | 10,950 | +15.87% | 368,100 | 905億575万 | +33.18% |
| 02/13 | 16:00 ヒト(同種) iPS細胞由来心筋細胞シートに関する部会議題掲載のお知らせ |
| 02/13 | 15:30 営業外収益の計上に関するお知らせ |
| 02/13 | 15:30 通期連結業績予想の修正に関するお知らせ |
| 02/13 | 15:30 2026年3月期第3四半期決算説明資料 |
| 02/13 | 15:30 2026年3月期第3四半期決算短信〔日本基準〕(連結) |
| 02/13 | 8,370 | 9,840 | 8,200 | 9,450 | +11.7% | 772,300 | 781億770万 | +17.09% |
| 02/06 | 16:15 関西財界セミナー2026「特別賞」受賞のお知らせ |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
